logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Anna Minchom

the royal marsden hospital and the institute of cancer research
H指数:26
被引数:2,600

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

IAP antagonist tolinapant (ASTX660) in combination with pembrolizumab in advanced solid tumors: a phase I trial

IAP拮抗剂托利那潘特（ASTX660）联合帕博利珠单抗治疗晚期实体瘤：一项I期临床试验

Nature Communications
IF15.7
2026-09-300
OA
Crescens Tiu; Wing Yau; Tencho Tenev; Daniel Lionarons; Ching Leung; Victoria Sanchez-Perez; Giovanni Codacci-Pisanelli; Xiaoran Lai; Anna Zachariou; Aasia Hussain; Toby Prout; Mona Parmar; Bindu Baikady; Maria Goicoechea; Scott Layzell; Naomi Guppy; Ioannis Roxanis; Thomas Lund; Diego Carlos Dos Reis; Camila Pereira Almeida; Tatiany Luiza Silveira; Ana Ferreira; Bora Gurel; Claudia Bertan; Mateus Crespo; Penny Flohr; Ann-Marie Baker; Trevor Graham; Luis Zapata; Claudio Salas; Soham Mandal; Alan Dunlop; Martin Sims; George Ward; Tomoko Smyth; Simone Jueliger; Matthew Davis; Ilya Potapov; Aram Oganesian; Danna Chan; Mattias Leino; Subham Basu; Andre Samson; James M. Murphy; Nina Tunariu; Edward W. Johnston; Alistair Ring; Nick Turner; Andrew N. J. Tutt; Amanda Swain; Anna Minchom; Adam Sharp; Alec Paschalis; Udai Banerji; Johann de Bono; Bristi Basu; Christina Yap; Syed Haider; Juanita Lopez; Pascal Meier
A practical toolkit with recommendations for analysing and visualising patient-reported outcomes in early phase dose-finding oncology trials (OPTIMISE-AR)

早期剂量探索性肿瘤临床试验中患者报告结局的分析与可视化实用工具包与建议（OPTIMISE-AR）

The Lancet Oncology
IF0
2026-03-170
PRE
Emily Alger; Antoine Regnault; Amylou C Dueck; Madeline Pe; Michael J Grayling; Melanie J Calvert; Aaron R Hansen; Olga Kholmanskikh; Julia Lai-Kwon; J Jack Lee; Anna Minchom; Yu Qiao; Khadija Rerhou Rantell; Jessica Roydhouse; Claire Snyder; Stefan N Symeonides; Nolan A Wages; Roger Wilson; Christina Yap
MDX-2001-101 study protocol: a phase I/IIa, multicenter, first-in-human, open-label clinical trial evaluating MDX2001 monotherapy in patients with advanced solid tumors

MDX-2001-101研究方案：一项评估MDX2001单药治疗在晚期实体瘤患者中的I/IIa期、多中心、首次人体、开放标签临床试验

Future Oncology
IF2.6
2026-01-010
OA
Dumbrava, Ecaterina; Minchom, Anna; Henry, Jason; Johnson, Melissa; Sommerhalder, David; Merchan, Jaime; Heist, Rebecca; Cabanas, Elena Garralda; Cotreau, Monette; Goenaga, Anne-Laure; Burzyn, Dalia; Makris, Lukas; Culm, Kerry; Abbadessa, Giovanni
First-in-human study of a thorium-227-labeled mesothelin-targeting antibody-chelator conjugate (MSLN-TTC), in patients with malignant mesothelioma and other solid tumors

首次人体研究：一种钍-227标记的间皮素靶向抗体-螯合剂偶联物（MSLN-TTC）在恶性间皮瘤及其他实体瘤患者中的应用

ESMO Open
IF8.3
2025-11-200
OAAI
A. Minchom; O. Lindén; D.G. Knapen; R. Hassan; F.I. Lin; K. Jalkanen; V. Subbiah; A. Tafuri; D. Ferreira; V. Jardine; A. Cleton; J. Pinkert; F. Bladt; H. Hennekes; E.F. Smit
Defactinib with avutometinib in patients with solid tumors: the phase 1 FRAME trial

德法替尼联合阿瓦替尼治疗实体瘤患者: 1期框架试验

Nature Medicine
IF50
2025-06-270
OAAI
Susana Banerjee; Matthew G. Krebs; Alastair Greystoke; Alvaro Ingles Garces; Vicky Sanchez Perez; Angelika Terbuch; Rajiv Shinde; Reece Caldwell; Rafael Grochot; Mahtab Rouhifard; Ruth Ruddle; Bora Gurel; Karen Swales; Nina Tunariu; Toby Prout; Mona Parmar; Stefan Symeonides; Jan Rekowski; Christina Yap; Adam Sharp; Alec Paschalis; Juanita Lopez; Anna Minchom; Johann Sebastian de Bono; Udai Banerji
Advancing patient-centric care: integrating patient reported outcomes for tolerability assessment in early phase clinical trials - insights from an expert virtual roundtable

推进以患者为中心的护理: 在早期临床试验中整合患者报告的结果进行耐受性评估-来自专家虚拟圆桌会议的见解

ECLINICALMEDICINE
IF10
2024-10-010
OAAI
Yap, Christina; Aiyegbusi, Olalekan Lee; Alger, Emily; Basch, Ethan; Bell, Jill; Bhatnagar, Vishal; Cella, David; Collis, Philip; Dueck, Amylou C.; Gilbert, Alexandra; Gnanasakthy, Ari; Greystoke, Alastair; Hansen, Aaron R.; Kamudoni, Paul; Kholmanskikh, Olga; King-Kallimanis, Bellinda L.; Krumholz, Harlan; Minchom, Anna; O'Connor, Daniel; Petrie, Joan; Piccinin, Claire; Rantell, Khadija Rerhou; Rauz, Saaeha; Retzer, Ameeta; Rizk, Steven; Wagner, Lynne; Sasseville, Maxime; Seymour, Lesley K.; Weber, Harald A.; Wilson, Roger; Calvert, Melanie; Peipertf, John Devin
Interim results of a phase I study of SGN-PDL1V (PF-08046054) in patients with PDL1-expressing solid tumors

SGN-PDL1V（PF-08046054）在PD-L1表达实体瘤患者中的I期研究中期结果

ANNALS OF ONCOLOGY
IF65.4
2024-09-012
PRE
Oliva, M.; Ochsenreither, S.; Le Tourneau, C.; Champiat, S.; Saleh, R.; Burkitt, K.; Nabell, L.; Steeghs, N.; Spreafico, A.; Minchom, A. R.; Patnaik, A.; Call, J. A.; Fontana, E.; Kotecki, N.; Garralda, E.; Zivi, A.; Riess, J. W.; Gupta, S.; Zhang, R.; Gillison, M.
A phase I/IIa first-in-human clinical trial evaluating MDX2001, a multi-specific antibody in patients with advanced solid tumor malignancies

一项评估MDX2001（一种多特异性抗体）在晚期实体瘤恶性肿瘤患者中的首次人体I/IIa期临床试验。

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Minchom, A. R.; Culm, K.; Garmey, E.; Makris, L.; Johnson, M. L.; Sommerhalder, D.; Garralda, E.; Henry, J.; Yang, M.; Mei, L.; Cotreau, M. M.; Goenaga, A-L.; Burzyn, D.; Yang, Z-Y.; Wei, R.; Chhaljani, V.; Mascola, J.; Nabel, G.; Dumbrava, E. E.
Proof-of-concept and preliminary efficacy of triple IAP blockade to maximize immunogenic cell death and induce efficient adaptive immune response: First report on the ASTEROID phase 1 trial
CANCER RESEARCH
IF16.6
2024-04-050
PRE
Tiu, Crescens; Yau, Wing; Sanchez-Perez, Victoria; Codacci-Pisanelli, Giovanni; Leung, Ching; Andrews, Eden S.; Basu, Bristi; Zachariou, Anna; Prout, Toby; Parmar, Mona; Turner, Alison; Lai, Xiaoran; Yin, Zhulin; Swales, Karen E.; Haider, Syed; Lund, Thomas; Dos Reis, Diego C.; Silveira, Tatiany L.; Dunlop, Alan S.; Baker, Ann-Marie; Gurel, Bora; Ferreira, Ana; Bertan, Claudia; Tunariu, Nina; Johnston, Edward W.; Ring, Alistair; Tenev, Tencho; Smyth, Tomoko; Jueliger, Simone; Banerji, Udai; de Bono, Johann S.; Paschalis, Alec; Sharp, Adam; Minchom, Anna; Yap, Christina; Meier, Pascal; Lopez, Juanita S.
Safety and preliminary activity of the selective ALK inhibitor NVL-655 in patients with ALK fusion-positive solid tumors
MOLECULAR CANCER THERAPEUTICS
IF5.5
2023-12-014
PRE
Lin, Jessica J.; Johnson, Melissa; Felip, Enriqueta; Ou, Sai-Hong Ignatius; Besse, Benjamin; Baik, Christina; Mazieres, Julien; Elamin, Yasir; Reuss, Joshua E.; Minchom, Anna; Swalduz, Aurelie; Pavlakis, Nick; Liu, Geoffrey; Gadgeel, Shirish; Camidge, D. Ross; Green, Jennifer A.; Shen, Junwu; Soglia, John; Sun, Yuting; Zhu, Viola W.; Drilon, Alexander
Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: The phase I/II first-in-human MATINS trial
CELL REPORTS MEDICINE
IF10.6
2023-12-017
OAAI
Rannikko, Jenna H.; Verlingue, Loic; Miguel, Maria de; Pasanen, Annika; Robbrecht, Debbie; Skytta, Tanja; Iivanainen, Sanna; Shetty, Shishir; Ma, Yuk Ting; Graham, Donna M.; Arora, Sukeshi Patel; Jaakkola, Panu; Yap, Christina; Xiang, Yujuan; Mandelin, Jami; Karvonen, Matti K.; Jalkanen, Juho; Karaman, Sinem; Koivunen, Jussi P.; Minchom, Anna; Hollmen, Maija; Bono, Petri
Amivantamab plus lazertinib in osimertinib-relapsed EGFR-mutant advanced non-small cell lung cancer: a phase 1 trial
NATURE MEDICINE
IF50
2023-09-1429
OAAI
Cho, Byoung Chul; Kim, Dong-Wan; Spira, Alexander I.; Gomez, Jorge E.; Haura, Eric B.; Kim, Sang-We; Sanborn, Rachel E.; Cho, Eun Kyung; Lee, Ki Hyeong; Minchom, Anna; Lee, Jong-Seok; Han, Ji-Youn; Nagasaka, Misako; Sabari, Joshua K.; Ou, Sai-Hong Ignatius; Lorenzini, Patricia; Bauml, Joshua M.; Curtin, Joshua C.; Roshak, Amy; Gao, Grace; Xie, John; Thayu, Meena; Knoblauch, Roland E.; Park, Keunchil

研究方向

暂未获取到该数据
U
Udai Banerji
H 指数:52论文数:647被引数:1.2万
C
Christina Yap
H 指数:38论文数:235被引数:7,146
J
Johann S. de Bono
H 指数:160论文数:2,491被引数:13.5万
M
Mary O’Brien
H 指数:63论文数:464被引数:2.6万
J
Juanita Lopez
H 指数:36论文数:332被引数:1.0万
S
Sanjay Popat
H 指数:65论文数:804被引数:3.0万
J
Jaishree Bhosle
H 指数:20论文数:130被引数:1,622
N
Nina Tunariu
H 指数:50论文数:440被引数:1.8万
M
Mona Parmar
H 指数:13论文数:81被引数:689
A
Adam Sharp
H 指数:41论文数:495被引数:6,165